Cardiology
doi: 10.25005/2074-0581-2020-22-2-241-245
COMPARATIVE ANALYSIS OF C-REACTIVE PROTEIN AND RED BLOOD CELLS DISTRIBUTION WIDTH LEVELS IN SUBGROUPS DEPENDING ON THE SEVERITY OF HYPERLIPIDEMIA ACCORDING TO LABORATORY REGISTRY DATA

O.V. Gaisenok

United Hospital with Outpatient Department, Moscow, Russian Federation

Objective: To identify patients with severe hyperlipidemia and to analyze red cells distribution width (RDW) and C-reactive protein (CRP) levels in subgroups depending on the severity of hyperlipidemia.

Methods: All patients who underwent complete blood count, total cholesterol (TC) and LDL tests in our hospital from January to December 2016 were included in the study. CRP data were added to the database, if available. Criteria for severe hyperlipidemia were accepted LDL values of 5.0 mmol/L and more in this study.

Results: 8056 patient records were included in the final analysis. Detection of severe hyperlipidemia in this population by this criteria was 8.0%. A comparative analysis of RDW and CRP depending on the presence of severe hyperlipidemia was carried out for the whole study group and for patients with circulatory system diseases (CSD). Differences in the level of CRP and RDW were obtained depending on the presence of severe hyperlipidemia for both groups of patients. But statistically significant differences were obtained only in RDW level in patients with CSD. Among them, the RDW level in patients with severe hyperlipidemia was lower: 12.9±0.8 (n=173) vs 13.2±0.8 (n=2119), p=0.007.

Conclusion: Statistically significant differences were found in the level of RDW in patients with severe hyperlipidemia only in the group of patients with CSD (but not for the whole group). RDW should be considered as an additional biomarker in patients with cardiovascular diseases.

Keywords: C-reactive protein, red blood cells distribution width, LDL, screening, severe hyperlipidemia.

Download file:

References
  1. Richards AM. Future biomarkers in cardiology: my favourites. Eur Heart J Suppl. 2018;20(Suppl GE):G37-G44.
  2. Pencina MJ, D’Agostino RBSr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119(24):3078-84. Available from: https://doi.org/10.1161/ CIRCULATIONAHA.108.816694
  3. Assmann G, Schulte H, Cullen P. New and classical risk factors – the Münster heart study (PROCAM). Eur J Med Res. 1997;2(6):237-42.
  4. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003. Available from: https://doi. org/10.1016/s0195-668x(03)00114-3
  5. Clayton TC, Lubsen J, Pocock SJ, Vokó Z, Kirwan BA, Fox KA, et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomized trial cohort of patients. BMJ. 2005;331(7521):869. Available from: https://doi.org/10.1136/ bmj.38603.656076.63
  6. Ikonomidis I, Michalakeas CA, Parissis J, Paraskevaidis I, Ntai K, Papadakis I, et al. Inflammatory markers in coronary artery disease. Biofactors. 2012;38(5):320-8. Available from: https://doi.org/10.1002/biof.1024
  7. Berg J, Halvorsen AR, Bengtson MB, Taskén KA, Mælandsmo GM, Yndestad A, et al. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer. 2018;18(1):739. Available from: https://doi.org/10.1186/s12885-018-4659-0
  8. Qian J, Tikk K, Werner S, Balavarca Y, Saadati M, Hechtner M, et al. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation. J Clin Epidemiol. 2018;104:24-34. Available from: https://doi.org/10.1016/j.jclinepi.2018.07.016
  9. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359(18):1897-908. Available from: https://doi.org/10.1056/NEJMoa0707402
  10. Veeranna V, Zalawadiya SK, Panaich S, Patel KV, Afonso L. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES. Int J Cardiol. 2013;168(6):5156-61. Available from: https://doi.org/10.1016/j.ijcard.2013.07.109
  11. Lippi G, Plebani M. Red blood cell distribution width (RDW) and human pathology. One size fits all. Clin Chem Lab Med. 2014;52(9):1247-9. Available from: https://doi.org/10.1515/cclm-2014-0585
  12. Lappé JM, Horne BD, Shah SH, May HT, Muhlestein JB, Lappé DL, et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta. 2011;412(23-24):2094-9. Available from: https://doi. org/10.1016/j.cca.2011.07.018
  13. Gul M, Uyarel H, Ergelen M, Karacimen D, Ugur M, Turer A, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis. 2012;23(5):330-6. Available from: https://doi. org/10.1097/MCA.0b013e3283564986
  14. Majercik S, Fox J, Knight S, Horne BD. Red cell distribution width is predictive of mortality in trauma patients. J Trauma Acute Care Surg. 2013;74(4):1021- 6. Available from: https://doi.org/10.1097/TA.0b013e3182826f02
  15. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277(1-2):103-8. Available from: https://doi.org/10.1016/j.jns.2008.10.024
  16. Hsieh YP, Chang CC, Kor CT, Yang Y, Wen YK, Chiu PF. The predictive role of red cell distribution width in mortality among chronic kidney disease patients. PLoS One. 2016;11(12):e0162025. Available from: https://doi.org/10.1371/ journal.pone.0162025
  17. Ellingsen TS, Lappegård J, Skjelbakken T, Braekkan SK, Hansen JB. Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study. Haematologica. 2015;100(10):e387-9. Available from: https://doi.org/10.3324/haematol.2015.129601
  18. Martínez-Velilla N, Ibáñez B, Cambra K, Alonso-Renedo J. Red blood cell distribution width, multimorbidity, and the risk of death in hospitalized older patients. Age (Dordr). 2012;34(3):717-23. Available from: https://doi. org/10.1007/s11357-011-9254-0
  19. Arbel Y, Weitzman D, Raz R, Steinvil A, Zeltser D, Berliner S, et al. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost. 2014;111(2):300-7. Available from: https://doi.org/10.1160/TH13-07-0567
  20. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357(9251):165-8. Available from: https://doi. org/10.1016/S0140-6736(00)03587-X
  21. Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, et al. Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs. Pharmacoepidemiol Drug Saf. 2018;27(10):1147-50. Available from: https://doi.org/10.1002/pds.4368.
  22. Olson KL, Wood MD, Delate T, Lash LJ, Rasmussen J, Denham AM, et al. Positive predictive values of ICD-9 codes to identify patients with stroke or TIA. Am J Manag Care. 2014;20(2):e27-34.
  23. Yue J, Lian X, Yue P, Xiang D, Wang C. Impact on major CBC parameters caused by different types of lipids in patient plasma. Int J Lab Hematol. 2017;40(1):e1-e3. Available from: https://doi.org/doi: 10.1111/ijlh.12706
  24. Rasouli M, Kiasari AM, Bagheri B. Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease. Clin Chim Acta. 2007;377(1-2):127- 32. Available from: https://doi.org/10.1016/j.cca.2006.09.009

Author information:

Gaisenok Oleg Vladimirovich Candidate of Medical Sciences, Head of Department of Cardiology and Internal Diseases, United Hospital with Outpatient Department Scopus ID: 55943847600 ORCID ID: 0000-0002-2379-0450 Author ID: 667223 SPIN: 9742-0638 E-mail: ovg.07@bk.ru


Information about support in the form of grants, equipment, medications

The author did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Gaisenok Oleg Vladimirovich
Candidate of Medical Sciences, Head of Department of Cardiology and Internal Diseases, United Hospital with Outpatient Department


119285, Russian Federation, Moscow, Michurinsky Ave., 6

E-mail: ovg.07@bk.ru

Materials on the topic:
  1. DYSLIPIDEMIA AND SEVERITY OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND SUBCLINICAL HYPOTHYROIDISM
  2. PREVALENCE OF CORONARY ARTERY DISEASE IN YOUNG AND MIDDLE AGE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
  3. SOME FEATURES OF PERIPHERAL BLOOD COMPOSITION IN PATIENTS WITH CORONARY ARTERY DISEASE AND ARTERIAL HYPERTENSION
  4. CORONARY ARTERY CALCIFICATION IN LIVER TRANSPLANT RECIPIENTS
  5. GENETIC ASPECTS OF ATRIAL FIBRILLATION ON THE BACKGROUND OF ARTERIAL HYPERTENSION IN COMBINATION WITH NONCARDIAC DISEASES
  6. APPLICATION OF A TWO-STEP SCREENING SYSTEM IN COMPLEX EVALUATION OF PSYCHOSOCIAL STATUS IN PATIENTS WITH CORONARY HEART DISEASE
  7. FEATURES OF REMODELLING OF THE LEFT VENTRICULAR MYOCARDIUM IN PATIENTS WITH ARTERIAL HYPERTENSION OF ELDERLY AGE WITH COMORBID DEPRESSION
  8. TREATMENT OF CHRONIC HEART FAILURE IN MIDDLE-AGED MEN WITH DEPRESSION
  9. GENDER STEREOTYPES OF THE PERSONALITY AND FAMILY SETTINGS IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
  10. THE INFLUENCE OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON SPECTRAL INDICES OF HEART RHYTHM IN PATIENTS WITH HIV INFECTION

◄ Back to the list